Biofrontera Inc. (BFRI)
- Simply Wall St.
Biofrontera Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Biofrontera ( NASDAQ:BFRI ) Second Quarter 2024 Results Key Financial Results Revenue: US$7.84m (up 34% from 2Q 2023...
- GlobeNewswire
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results for the three and six months ended June 30, 2024 and provided a business update. Highlights from the second quarter of 2024 and subsequent weeks included the following: Total revenues for the second quarter of 2024 were $7.8 million, a 34% increase from the same period of the prio
- ACCESSWIRE
Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024
WOBURN, MA / ACCESSWIRE / August 9, 2024 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended ...
